EU-US trade deal leaves future of pharma tariffs uncertain
Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a US national security investigation that could later impose duties of up to 15%.
https://anessoft.com/blog/ar/macron-evoque-une-possible-reprise-du-dialogue-avec-vladimir-poutine
Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a US national security investigation that could later impose duties of up to 15%.
What's Your Reaction?
